Evofem Biosciences, Inc.EVFMOTCMARKET
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank58
3Y CAGR-58.7%
5Y CAGR-22.5%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
-58.7%/yr
Quarterly compound
5Y CAGR
-22.5%/yr
Recent deceleration
Percentile
P58
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 12.05% |
| Q2 2025 | -286.61% |
| Q1 2025 | 131.48% |
| Q4 2024 | -28.41% |
| Q3 2024 | -275.06% |
| Q2 2024 | 128.09% |
| Q1 2024 | -127.48% |
| Q4 2023 | -103.20% |
| Q3 2023 | 871.27% |
| Q2 2023 | -263.55% |
| Q1 2023 | 71.76% |
| Q4 2022 | -109.31% |
| Q3 2022 | 171.05% |
| Q2 2022 | -295.07% |
| Q1 2022 | 38.15% |
| Q4 2021 | 30.39% |
| Q3 2021 | -121.57% |
| Q2 2021 | 27.57% |
| Q1 2021 | -13.68% |
| Q4 2020 | -35.78% |
| Q3 2020 | 43.23% |
| Q2 2020 | -175.08% |
| Q1 2020 | -50.55% |
| Q4 2019 | 7.83% |
| Q3 2019 | 61.08% |
| Q2 2019 | -96.20% |
| Q1 2019 | -20.61% |
| Q4 2018 | 18.72% |
| Q3 2018 | 20.71% |
| Q2 2018 | 66.34% |
| Q1 2018 | -2826.38% |
| Q4 2017 | -30.64% |
| Q3 2017 | 35.81% |
| Q2 2017 | 6.63% |
| Q1 2017 | -52.82% |
| Q4 2016 | 16.53% |
| Q3 2016 | 0.00% |